Company
ersteq_img
Target-Centric AI Drug Discovery Meets the Future
Also known as ERSTEQ
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Daejeon, South Korea
- Customers
- pharmaceutical companies, biotechs, national research institutes, universities and hospitals
Claim, correct or request removal
Record updated 18 September 2026
About
Target-centric approach enables the rational design of next-generation therapeutics (—such as PPI modulators and molecular glue degraders—) expanding treatment options for resistant and previously undruggable targets.
Products
- Other
- ERST-LAB
- Other
- GlueHunter
- Other
- LeadHunter
Loading relationship preview